Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
US FDA Suspends Valneva’s Ixchiq Based On Four New Serious AE Reports
Aug 25 2025
•
By
Sue Sutter
Suspending a BLA is an unusual move for the US FDA.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Vaccines
More from United States